[HTML][HTML] Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021)

RM Kariyawasam, DA Julien, DC Jelinski… - … Resistance & Infection …, 2022 - Springer
Abstract Background Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral
and bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients …

[HTML][HTML] Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021)

RM Kariyawasam, DA Julien, DC Jelinski… - … and Infection Control, 2022 - ncbi.nlm.nih.gov
Background Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral and
bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients …

[PDF][PDF] Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021)

RM Kariyawasam, DA Julien, DC Jelinski… - … & Infection Control, 2022 - prism.ucalgary.ca
Abstract Background: Pneumonia from SARS‑CoV‑2 is difficult to distinguish from other viral
and bacterial etiologies. Broad‑spectrum antimicrobials are frequently prescribed to patients …

[HTML][HTML] Antimicrobial Resistance (AMR) in COVID-19 Patients: A Systematic Review and Meta-Analysis (November 2019-June 2021)

RM Kariyawasam, DA Julien, DC Jelinski, SL Larose… - 2021 - europepmc.org
Background: Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral and
bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients …

Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).

RM Kariyawasam, DA Julien, DC Jelinski… - … and Infection Control, 2022 - go.gale.com
Background Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral and
bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients …

[HTML][HTML] Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021)

RM Kariyawasam, DA Julien… - Antimicrobial …, 2022 - aricjournal.biomedcentral.com
Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral and bacterial
etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients hospitalized …

[PDF][PDF] Antimicrobial Resistance (AMR) in COVID-19 Patients: A Systematic Review and Meta-Analysis (November 2019-June 2021)

RM Kariyawasam, DA Julien, DC Jelinski, SL Larose… - scholar.archive.org
Background Pneumonia from SARS-CoV-2 is di cult to distinguish from other viral and
bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients …

Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021)

RM Kariyawasam, DA Julien… - Antimicrobial …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral and
bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients …

Antimicrobial Resistance (AMR) in COVID-19 Patients: A Systematic Review and Meta-Analysis (November 2019–June 2021)

RM Kariyawasam, DA Julien, DC Jelinski… - Available at SSRN … - papers.ssrn.com
Background: Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral and
bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients …

[HTML][HTML] Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).

RM Kariyawasam, DA Julien… - … Resist Infect Control, 2022 - pesquisa.bvsalud.org
BACKGROUND: Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral and
bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients …